| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/02/1997 | EP0765666A1 Inhibition of irregular binding of lens cells |
| 04/02/1997 | EP0765664A1 Stable aqueous suspension of mesalazine for topical use |
| 04/02/1997 | EP0765660A2 Microcapsules comprising 2-piperazinone-1-acetic acid compounds |
| 04/02/1997 | EP0765659A1 Delayed drug-releasing microspheres |
| 04/02/1997 | EP0765173A1 A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes |
| 04/02/1997 | EP0765159A1 Spin encapsulation apparatus and method of use |
| 04/02/1997 | EP0765158A1 Active substance carrier for the controlled release of active substances in the gastro-intestinal tract with delayed passage through the pylorus |
| 04/02/1997 | EP0765157A1 Pellets |
| 04/02/1997 | EP0765156A1 Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets |
| 04/02/1997 | EP0765155A1 NON-IRRITANT AQUEOUS LIPOSOME DISPERSIONS CONTAINING $g(a)-HYDROXYCARBOXYLIC ACIDS, $g(a)-KETOCARBOXYLIC ACIDS AND/OR SALICYCLIC ACID IN THEIR SALT FORMS |
| 04/02/1997 | EP0765151A1 Antibacterial oil-in-water emulsions |
| 04/02/1997 | EP0663951A4 Chitosan matrices for encapsulated cells. |
| 04/02/1997 | EP0576456B1 Pharmaceutical compositions for the treatment of skin disorders |
| 04/02/1997 | EP0507851B1 Quinolone carboxylic acid--metal ion--acid complexes |
| 04/02/1997 | CN2250759Y Sealed water-proof plaster |
| 04/02/1997 | CN1146773A Porous particles aggregate and method therefor |
| 04/02/1997 | CN1146725A Gel for treatment of skin diseases and for disinfection of the skin |
| 04/02/1997 | CN1146722A Taxane class derivative based pharmaceutical compositions |
| 04/02/1997 | CN1146721A Systemic drug delivery system through application on nails |
| 04/02/1997 | CN1146720A New pharmaceutical formulation and preparation process |
| 04/02/1997 | CN1146489A Process for deactivating or destroying microorganisms |
| 04/02/1997 | CN1146416A Bag for medicine or food |
| 04/02/1997 | CN1146361A Aitongning oral liquid (for relieving cancer pain) |
| 04/02/1997 | CN1146359A Feijiwan pill (for lung disease) and preparation method |
| 04/02/1997 | CN1146358A Shengkang injection solution (for nephrosis) and preparation technology |
| 04/02/1997 | CN1146355A Dianyansan powder medicine for acute waist sprain and preparation method thereof |
| 04/02/1997 | CN1146345A Quick-effect traditional Chinese medicine for curing difficult and complicated gynopathy |
| 04/02/1997 | CN1146344A Bear gall cooling cream |
| 04/02/1997 | CN1146343A External compress paste for discopathy |
| 04/02/1997 | CN1146342A Complex ant capsule |
| 04/02/1997 | CN1146336A Aerosol for driver with cooling and refreshing function |
| 04/02/1997 | CN1034391C Preparation for intravaginal devices |
| 04/01/1997 | US5616621 Taste masking liquids |
| 04/01/1997 | US5616608 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 04/01/1997 | US5616602 Skin disorders |
| 04/01/1997 | US5616598 Cosmetic composition comprising a fatty substance and an aqueous polymer dispersion and the use thereof |
| 04/01/1997 | US5616588 Rapamycin formulation for IV injection |
| 04/01/1997 | US5616587 Aqueous risperidone formulations |
| 04/01/1997 | US5616482 Protein fragments including an enzyme fragment a of diphtheria toxin bound together and also bound to a polypeptide ligand able to bind to selected cells; antitumor and carcinogenic agents |
| 04/01/1997 | US5616361 Free-flowing, compressible grains |
| 04/01/1997 | US5616346 Sodium phosphate mixtures |
| 04/01/1997 | US5616345 Pelletizing the powder drug for sustained release |
| 04/01/1997 | US5616344 Apparatus and process for strengthening low density compression dosage units and product therefrom |
| 04/01/1997 | US5616343 Cross-linked amylose as a binder/disintegrant in tablets |
| 04/01/1997 | US5616342 Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| 04/01/1997 | US5616341 High drug:lipid formulations of liposomal antineoplastic agents |
| 04/01/1997 | US5616340 Process for making a hard-candy based oral pharmaceutical lozenge containing an antacid |
| 04/01/1997 | US5616334 Complex of lipid and hydrophobic drug such as amphotericin b; fda orange book listed patent |
| 04/01/1997 | US5616330 Taxine, a triglyceride, water and a surfactant; anticarcinogenic agent |
| 04/01/1997 | US5616315 Particles including degradable material and anti-microbial agent |
| 04/01/1997 | US5616311 Non-crosslinked protein particles for therapeutic and diagnostic use |
| 04/01/1997 | US5616246 Hydrophilic membranes for electrochemical devices and method for preparing same |
| 04/01/1997 | US5616123 Delivery of solid drug compositions |
| 04/01/1997 | US5615492 Drying of water-containing useful materials or mixtures thereof with superheated steam |
| 04/01/1997 | CA2026030C Maltodextrin/defoaming composition combinate |
| 04/01/1997 | CA1339034C Platinum complexes of single isomer neoalkyl acids |
| 04/01/1997 | CA1339031C Method of preserving ophthalmic solutions and compositions therefor |
| 04/01/1997 | CA1339030C Glassy sugar matrix for controlled administration of beneficial agent |
| 04/01/1997 | CA1339029C Transparent composition |
| 03/29/1997 | CA2186709A1 Sustained-release preparation |
| 03/27/1997 | WO1997011141A1 Fractionated vegetable oil |
| 03/27/1997 | WO1997010851A2 Nucleic acid delivery vehicle |
| 03/27/1997 | WO1997010849A1 Copolymeric micelle drug composition and method for the preparation thereof |
| 03/27/1997 | WO1997010844A1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/27/1997 | WO1997010835A1 Anti-intoxication composition |
| 03/27/1997 | WO1997010826A1 Pharmaceutical formulation |
| 03/27/1997 | WO1997010820A1 Stable vitamin c preparation |
| 03/27/1997 | WO1997010818A1 Method and composition for treating mammalian diseases caused by inflammatory response |
| 03/27/1997 | WO1997010814A1 Propofol nanodispersions |
| 03/27/1997 | WO1997010812A2 Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
| 03/27/1997 | WO1997010811A1 Nanoparticles in photodynamic therapy |
| 03/27/1997 | WO1997010810A2 Pharmaceutical granules |
| 03/27/1997 | WO1997010809A1 Lyophilized thioxanthenone antimumor agents |
| 03/27/1997 | WO1997010808A1 Lipoic acid in topical compositions |
| 03/27/1997 | WO1997010807A1 Improved cell encapsulation device |
| 03/27/1997 | WO1997010806A1 Aerosol compositions |
| 03/27/1997 | WO1997010805A1 Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds |
| 03/27/1997 | WO1997010725A1 Novel process |
| 03/27/1997 | WO1997004756A3 Methacrylate backbone surfactants in nanoparticulate formulations |
| 03/27/1997 | WO1997004750A3 Process for preparing solid dosage forms of very low-dose drugs |
| 03/27/1997 | WO1997004745A3 Ophthalmological composition for protecting the eyes from irritation caused by ozone and/or uv radiation |
| 03/27/1997 | WO1997002812A3 Layered tablet for the controlled release of active substances |
| 03/27/1997 | WO1996041621A3 Osmotic-delivery devices having vapor-permeable coatings |
| 03/27/1997 | WO1996040082A3 Apparatus and method for delivering a biologically active compound into a biological environment |
| 03/27/1997 | WO1996039156A3 Phosphate-binding polymers for oral administration |
| 03/27/1997 | WO1996039153A3 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/27/1997 | CA2232444A1 Lyophilized thioxanthenone antitumor agents |
| 03/27/1997 | CA2231172A1 Nucleic acid delivery vehicle |
| 03/27/1997 | CA2230133A1 Composition comprising an oil soluble ingredient and emulsifiers with matching fatty acids |
| 03/27/1997 | CA2229796A1 Anti-intoxication composition |
| 03/27/1997 | CA2229285A1 Nanoparticles in photodynamic therapy |
| 03/26/1997 | EP0764441A1 Cosmetic or dermopharmaceutical patch containing at least one active agent, particularly an unstable one in an oxidative medium, and at least one hydroabsorbent in an anhydrous polymeric matrix |
| 03/26/1997 | EP0764439A2 Use of plant fats of foodstuff standard as emollient or consistency agent for cosmetics or pharmaceuticals |
| 03/26/1997 | EP0764346A1 High vertical aspect ratio thin film structures |
| 03/26/1997 | EP0764208A1 Bmp-9 compositions |
| 03/26/1997 | EP0764177A1 Cross-linked polymers for removing bile salts from a patient |
| 03/26/1997 | EP0764172A1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 03/26/1997 | EP0764047A1 Polymeric microbeads and method of preparation |
| 03/26/1997 | EP0764032A1 Stable gel formulation for topical treatment of skin conditions |